Establishment of NS3 tumor cell line expressing Hepatitis C virus Non-structural Protein 3 as valuable tool for HCV challenging in mice

Introduction: Hepatitis C virus (HCV) is one of the major medical problems. Human and chimpanzees are the only specific hosts which are naturally susceptible to HCV infection. Mice and other common laboratory animals are resistant to the virus, hence HCV prophylactic and therapeutic researches are v...

Full description

Bibliographic Details
Main Authors: MH Pouriayevali, T Bamdad, SM Sadat, F Sabahi, MR Aghasadeghi, SH Yazdani
Format: Article
Language:English
Published: Pasteur Institute of Iran 2016-05-01
Series:Vaccine Research
Subjects:
Online Access:http://vacres.pasteur.ac.ir/article-1-79-en.html
_version_ 1818287218729418752
author MH Pouriayevali
T Bamdad
SM Sadat
F Sabahi
MR Aghasadeghi
SH Yazdani
author_facet MH Pouriayevali
T Bamdad
SM Sadat
F Sabahi
MR Aghasadeghi
SH Yazdani
author_sort MH Pouriayevali
collection DOAJ
description Introduction: Hepatitis C virus (HCV) is one of the major medical problems. Human and chimpanzees are the only specific hosts which are naturally susceptible to HCV infection. Mice and other common laboratory animals are resistant to the virus, hence HCV prophylactic and therapeutic researches are very difficult and challenging. HCV non-structural protein 3 (NS3) is one of the most attractive targets for developing novel anti-HCV therapies as it is essential for the viral replication. This study was designed to produce stable SP2/0 tumor cell lines expressing NS3 of HCV for future basic and vaccine studies. Methods: A lentivector expressing NS3, named PCDH-NS3, was constructed by cloning of NS3 cDNA into downstream of CMV promoter of pCDH-CMV-MCS-EF1-Puro-GFP. The constructed plasmid was co-transfected with pMD2.G plasmid which encodes envelope VSV G protein and psPAX2 packaging plasmid into HEK-293T cells. The lentivector-containing supernatant was collected every 12 h for 72 h and NS3-Lentivector was concentrated by ultracentrifugation. Titers of the NS3 lentivector were estimated using flow cytometry. The SP2/0 cells were then infected by NS3 lentivector. Puromycin as a selective antibiotic was added to the culture for 2 weeks to select NS3 positive cells. A single transfected clone was obtained using limiting dilution. The 1st and 6th passages of the cells cultured in vitro were harvested and NS3 mRNA was detected for by RT-PC. Results: The results showed that NS3 expressing lentivector plasmids and the two other helper plasmids could be transfected into HEK293T efficiently and packaged successfully as a pseudo-lentivector. Finally, the detection of NS3 mRNA in the 1st and 6th passages of SP2/NS3 cells was confirmed by establishment of a stable cell line. Conclusion: SP2/0 Cell line with stable expression of NS3 can be used as a suitable tumor model to facilitate research on HCV vaccine in vitro and in mice model and it could be served as a valuable tool for pharmaceutical HCV research to pave the way for further research on NS3 vaccine function.
first_indexed 2024-12-13T01:37:00Z
format Article
id doaj.art-7ebf57c0b7fa42c7a7d0541709ff65bd
institution Directory Open Access Journal
issn 2383-2819
2423-4923
language English
last_indexed 2024-12-13T01:37:00Z
publishDate 2016-05-01
publisher Pasteur Institute of Iran
record_format Article
series Vaccine Research
spelling doaj.art-7ebf57c0b7fa42c7a7d0541709ff65bd2022-12-22T00:03:52ZengPasteur Institute of IranVaccine Research2383-28192423-49232016-05-0131914Establishment of NS3 tumor cell line expressing Hepatitis C virus Non-structural Protein 3 as valuable tool for HCV challenging in miceMH Pouriayevali0T Bamdad1SM Sadat2F Sabahi3MR Aghasadeghi4SH Yazdani5 Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran . Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran . Department of Hepatitis and AIDS, Pasteur Institute of Iran. Tehran, Iran. Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran . Department of Hepatitis and AIDS, Pasteur Institute of Iran. Tehran, Iran. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Introduction: Hepatitis C virus (HCV) is one of the major medical problems. Human and chimpanzees are the only specific hosts which are naturally susceptible to HCV infection. Mice and other common laboratory animals are resistant to the virus, hence HCV prophylactic and therapeutic researches are very difficult and challenging. HCV non-structural protein 3 (NS3) is one of the most attractive targets for developing novel anti-HCV therapies as it is essential for the viral replication. This study was designed to produce stable SP2/0 tumor cell lines expressing NS3 of HCV for future basic and vaccine studies. Methods: A lentivector expressing NS3, named PCDH-NS3, was constructed by cloning of NS3 cDNA into downstream of CMV promoter of pCDH-CMV-MCS-EF1-Puro-GFP. The constructed plasmid was co-transfected with pMD2.G plasmid which encodes envelope VSV G protein and psPAX2 packaging plasmid into HEK-293T cells. The lentivector-containing supernatant was collected every 12 h for 72 h and NS3-Lentivector was concentrated by ultracentrifugation. Titers of the NS3 lentivector were estimated using flow cytometry. The SP2/0 cells were then infected by NS3 lentivector. Puromycin as a selective antibiotic was added to the culture for 2 weeks to select NS3 positive cells. A single transfected clone was obtained using limiting dilution. The 1st and 6th passages of the cells cultured in vitro were harvested and NS3 mRNA was detected for by RT-PC. Results: The results showed that NS3 expressing lentivector plasmids and the two other helper plasmids could be transfected into HEK293T efficiently and packaged successfully as a pseudo-lentivector. Finally, the detection of NS3 mRNA in the 1st and 6th passages of SP2/NS3 cells was confirmed by establishment of a stable cell line. Conclusion: SP2/0 Cell line with stable expression of NS3 can be used as a suitable tumor model to facilitate research on HCV vaccine in vitro and in mice model and it could be served as a valuable tool for pharmaceutical HCV research to pave the way for further research on NS3 vaccine function.http://vacres.pasteur.ac.ir/article-1-79-en.htmlhcvns3lentivectortumor challenging model.
spellingShingle MH Pouriayevali
T Bamdad
SM Sadat
F Sabahi
MR Aghasadeghi
SH Yazdani
Establishment of NS3 tumor cell line expressing Hepatitis C virus Non-structural Protein 3 as valuable tool for HCV challenging in mice
Vaccine Research
hcv
ns3
lentivector
tumor challenging model.
title Establishment of NS3 tumor cell line expressing Hepatitis C virus Non-structural Protein 3 as valuable tool for HCV challenging in mice
title_full Establishment of NS3 tumor cell line expressing Hepatitis C virus Non-structural Protein 3 as valuable tool for HCV challenging in mice
title_fullStr Establishment of NS3 tumor cell line expressing Hepatitis C virus Non-structural Protein 3 as valuable tool for HCV challenging in mice
title_full_unstemmed Establishment of NS3 tumor cell line expressing Hepatitis C virus Non-structural Protein 3 as valuable tool for HCV challenging in mice
title_short Establishment of NS3 tumor cell line expressing Hepatitis C virus Non-structural Protein 3 as valuable tool for HCV challenging in mice
title_sort establishment of ns3 tumor cell line expressing hepatitis c virus non structural protein 3 as valuable tool for hcv challenging in mice
topic hcv
ns3
lentivector
tumor challenging model.
url http://vacres.pasteur.ac.ir/article-1-79-en.html
work_keys_str_mv AT mhpouriayevali establishmentofns3tumorcelllineexpressinghepatitiscvirusnonstructuralprotein3asvaluabletoolforhcvchallenginginmice
AT tbamdad establishmentofns3tumorcelllineexpressinghepatitiscvirusnonstructuralprotein3asvaluabletoolforhcvchallenginginmice
AT smsadat establishmentofns3tumorcelllineexpressinghepatitiscvirusnonstructuralprotein3asvaluabletoolforhcvchallenginginmice
AT fsabahi establishmentofns3tumorcelllineexpressinghepatitiscvirusnonstructuralprotein3asvaluabletoolforhcvchallenginginmice
AT mraghasadeghi establishmentofns3tumorcelllineexpressinghepatitiscvirusnonstructuralprotein3asvaluabletoolforhcvchallenginginmice
AT shyazdani establishmentofns3tumorcelllineexpressinghepatitiscvirusnonstructuralprotein3asvaluabletoolforhcvchallenginginmice